Aminopterin embryofetopathy

Preferred Label : Aminopterin embryofetopathy;

ICD-11 definition : Aminopterin/Methotrexate embryofetopathy is a syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.;

Details

Origin ID

492190859;

UMLS CUI

C0432367;

CISMeF manual mappings
- Aminopterin/methotrexate embryofetopathy [ORDO Disease]
Currated CISMeF NLP mapping
- Fetal aminopterin syndrome (disorder) [SNOMED CT concept]
- fetal aminopterin syndrome [SNOMED Notion]
See also inter- (CISMeF)
- Fetal Methotrexate Syndrome [NCIt concept]
Semantic type(s)
- Disease or Syndrome [UMLS semantic type]
UMLS correspondences (same concept)
- Aminopterin/methotrexate embryofetopathy [ORDO Disease]
- Fetal Methotrexate Syndrome [NCIt concept]
- Fetal aminopterin syndrome (disorder) [SNOMED CT concept]
- Fetal methotrexate syndrome [MedDRA LLT]
- Foetal methotrexate syndrome [MedDRA Preferred Term]
- fetal aminopterin syndrome [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients